Frequent: Gastric irritation (7%), vomiting (5%), and dyspepsia (2%).Psychiatric disturbances dostinex and pregnancy central nervous system (CNS): Altogether 51 percent of patients experienced side effects. Very frequent: Sleep disturbances (somnolence 18%, insomnia 11%), vertigo (27%), and depression (13%). Frequent: dostinex and pregnancy (4%).

needed][edit] UsesMonotherapy of Parkinson's disease in the New England Journal of Medicine on January 4, 2007, cabergoline was implicated along with pergolide in causing valvular heart disease.[2][3] Both drugs are ergot-derived dopamine agonists, although dostinex and pregnancy molecular skeletons are different. As a result of this, dostinex and pregnancy FDA removed pergolide from the combination.[edit] DosageParkinson's disease: Monotherapy: Initial dose should be 0.5 mg per week, slowly titrated to 4.5 mg per week, slowly titrated to 4.5 mg dostinex and pregnancy dostinex and pregnancy if necessary.Ablactation: According to specific treatment scheme.[edit] dostinex and pregnancy Dostinex at www.rxlist.com. dostinex and pregnancy on 2007-04-27. CabergolineFrom Wikipedia, the free encyclopedia(Redirected from Dostinex)Jump to: navigation, searchCabergolineSystematic (IUPAC) nameN-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]- 6-(2-propenyl)-8g-ergoline-8-carboxamideor1-[(6-allylergolin8?-yl)- carbonyl]-1- [3-(dimethylamino)propyl]-3-ethylureaIdentifiersCAS number 81409-90-7ATC code.

dyskinesia (4%) and hallucinations (4%).Cardiovascular: Approximately 30 percent of patients were affected. Very frequent: Nausea (30%).